Smith & Nephew plc

Smith & Nephew plc

SNN

$26.77

Updated: 23/09/2026, 18:10:28

Market Cap
$11.24B
Sector
Healthcare
Industry
Medical - Devices
Country
GB
Stock valuation chart
One-year closing share-price history for SNN
Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

USD
NYSE
CEO: Deepak S. Nath
Employees: 18,362
https://www.smith-nephew.com
Asset Summaries
Latest generated summaries for SNN

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SNN.
Share price
$26.77
Market cap
$11.24B
Exchange
NYSE
Currency
USD
CEO
Deepak S. Nath
Employees
18,362
IPO date
16/11/1999
Beta
0.6879999999999999
Last dividend
$0.00
Day range
$26.75 – $27.26
52-week range
$26.75 – $37.51
1-day performance
-2.67%
1-year performance
0.06%
Current drawdown (1Y)
-28.65%
CIK
0000845982
CUSIP
83175M205
ISIN
US83175M2052
Created
07/12/2025, 14:18:41
Last update
23/09/2026, 18:10:28

Track Smith & Nephew plc with an AI analyst

See which prediction-market events move SNN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.